The DOI matches its Crossref record; 64 of the 65 references it cites were found in a registry or an index.
Identification of miRNA Changes in Alzheimer's Disease Brain and CSF Yields Putative Biomarkers and Insights into Disease Pathways
Abstract
MicroRNAs have essential functional roles in brain development and neuronal specification but their roles in neurodegenerative diseases such as Alzheimer's disease (AD) is unknown. Using a sensitive qRT-PCR platform we identified regional and stage-specific deregulation of miRNA expression in AD patient brains. We used experimental validation in addition to literature to reveal how the deregulated brain microRNAs are biomarkers for known and novel pathways in AD pathogenesis related to amyloid processing, neurogenesis, insulin resistance, and innate immunity. We additionally recovered miRNAs from cerebrospinal fluid and discovered AD-specific miRNA changes consistent with their role as potential biomarkers of disease.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“We detected a relatively smaller number of miRNAs in CSF, compared to other miRNA profiling studies19,28.”
From Intra- and Inter-individual Variability of microRNA Levels in Human Cerebrospinal Fluid: Critical Implications for Biomarker Discovery (2017) · cites this paper as [28]
In the citing paper
“Although the level of miR-9-5p was downregulated in AD brains and EVs from CSF [47,48,49]”
From MicroRNAs in Extracellular Vesicles of Alzheimer’s Disease (2023) · cites this paper as [48]
In the citing paper
“Similar to miR-146a-5p, miR-132-3p was reported to be downregulated in AD in five independent studies [48,72,80,84] but up-regulated in AD in only one independent study [81].”
From MicroRNAs in Extracellular Vesicles of Alzheimer’s Disease (2023) · cites this paper as [48]
In the citing paper
“Among these miRNAs, miR-146a-5p [50,70,73,74,83] and miR-132-3p [48,72,80,81,84] were reported to be dysregulated in six independent AD studies, respectively.”
From MicroRNAs in Extracellular Vesicles of Alzheimer’s Disease (2023) · cites this paper as [48]
In the citing paper
“miR-125b-5p was upregulated in brains [36,48,50] and EVs from CSF of AD patients compared to HC [49,66].”
From MicroRNAs in Extracellular Vesicles of Alzheimer’s Disease (2023) · cites this paper as [48]
In the citing paper
“Substantial recent evidence has demonstrated that microRNAs (miRNAs) are dysregulated already early on in AD pathology [2–7].”
From microRNA-132 attenuates inflammation in induced pluripotent stem cell-derived microglia from Alzheimer’s disease patients (2026) · cites this paper as [4]
In the citing paper
“miR-92a-1-5p expression in AD brain is enhanced, while miR-501-3p expression is increased in both brain and serum of AD patients [41–43].”
From Neurodegenerative disease-associated microRNAs acting as signaling molecules modulate CNS neuron structure and viability (2025) · cites this paper as [43]
In the citing paper
“miR-92a-1-5p expression in AD brain is enhanced, while miR-501-3p expression is increased in both brain and serum of AD patients [41–43].”
From Neurodegenerative disease-associated microRNAs acting as signaling molecules modulate CNS neuron structure and viability (2025) · cites this paper as [43]
In the citing paper
“Both miRNAs are expressed in the human brain and are deregulated in AD [41–43, 54].”
From Neurodegenerative disease-associated microRNAs acting as signaling molecules modulate CNS neuron structure and viability (2025) · cites this paper as [43]
In the citing paper
“Many studies have detected extracellular/circulating miRNAs in biological fluids, such as plasma and serum (117, 118), cerebrospinal fluid (119), saliva (120), breast milk (121), urine, tears, colostrum, peritoneal fluid, bronchial lavage, seminal fluid (122), and ovarian follicular fluid (123).”
From Overview of MicroRNA Biogenesis, Mechanisms of Actions, and Circulation (2018) · cites this paper as [119]
Citations
Cites
Valadi, H., Ekström, K., Bossios, A., Sjöstrand, M., Lee, J. J., & Lötvall, J. O. (2007) · Nature Cell Biology · doi:10.1038/ncb1596 · Cited by 12,834
Mitochondrial Dysfunction and Oxidative Stress in Neurodegenerative Diseases
Lin, M. T., & Beal, M. F. (2006) · Nature · doi:10.1038/nature05292 · Cited by 6,455
Oncomirs—MicroRNAs with a role in cancer
Esquela-Kerscher, A., & Slack, F. J. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1840 · Cited by 5,884
Real-time quantification of microRNAs by stem-loop RT-PCR
Chen, C. (2005) · Nucleic Acids Research · doi:10.1093/nar/gni178 · Cited by 4,989
Taganov, K. D., Boldin, M. P., Chang, K.-J., & Baltimore, D. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0605298103 · Cited by 4,317
Association of apolipoprotein E allele ϵ4 with late‐onset familial and sporadic Alzheimer's disease
Saunders, A. M., Strittmatter, W. J., Schmechel, D., St. George-Hyslop, P. H., Pericak-Vance, M. A., Joo, S. H., Rosi, B. L., Gusella, J. F., Crapper-MacLachlan, D. R., Alberts, M. J., et al. (1993) · Neurology · doi:10.1212/wnl.43.8.1467 · Cited by 3,786
RAS Is Regulated by the let-7 MicroRNA Family
Johnson, S., Großhans, H., Shingara, J., Byrom, M., JARVIS, R., Cheng, A., Labourier, E., Reinert, K. L., Brown, D., & Slack, F. J. (2005) · Cell · doi:10.1016/j.cell.2005.01.014 · Cited by 3,699
MicroRNAs Modulate Hematopoietic Lineage Differentiation
Chen, C.-Z., Li, L., Lodish, H. F., & Bartel, D. P. (2004) · Science · doi:10.1126/science.1091903 · Cited by 3,257
A Century of Alzheimer's Disease
Goedert, M., & Spillantini, M. G. (2006) · Science · doi:10.1126/science.1132814 · Cited by 2,153
miR-122 regulation of lipid metabolism revealed by in vivo antisense targeting
Esau, C., Davis, S., Murray, S. F., Yu, X. X., Pandey, S. K., Pear, M., Watts, L., Booten, S. L., Graham, M., McKay, R., et al. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2006.01.005 · Cited by 2,082
Flagged first, then by citations
1 of the 65 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Items 101–200 of 945
Sheinerman, K. S., & Umansky, S. R. (2013) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2013.00150 · Cited by 175
Shaltiel, G., Hanan, M., Wolf, Y., Barbash, S., Kovalev, E., Shoham, S., & Soreq, H. (2012) · Brain Structure and Function · doi:10.1007/s00429-011-0376-z · Cited by 173
McKeever, P. M., Schneider, R., Taghdiri, F., Weichert, A., Multani, N., Brown, R. A., Boxer, A. L., Karydas, A., Miller, B., Robertson, J., et al. (2018) · Molecular Neurobiology · doi:10.1007/s12035-018-1032-x · Cited by 166
Differential expression of microRNAs in Alzheimer's disease brain, blood, and cerebrospinal fluid
Takousis, P., Sadlon, A., Schulz, J., Wohlers, I., Dobricic, V., Middleton, L., Lill, C. M., Perneczky, R., & Bertram, L. (2019) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2019.06.4952 · Cited by 173
miR‐132 loss de‐represses ITPKB and aggravates amyloid and TAU pathology in Alzheimer's brain
Salta, E., Sierksma, A., Vanden Eynden, E., & De Strooper, B. (2016) · EMBO Molecular Medicine · doi:10.15252/emmm.201606520 · Cited by 169
Jahangard, Y., Monfared, H., Moradi, A., Zare, M., Mirnajafi-Zadeh, J., & Mowla, S. J. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.00564 · Cited by 162
MicroRNAs in Neurodegenerative Diseases
(2017) · International Review of Cell and Molecular Biology · doi:10.1016/bs.ircmb.2017.04.002 · Cited by 168
Sheinerman, K. S., Toledo, J. B., Tsivinsky, V. G., Irwin, D., Grossman, M., Weintraub, D., Hurtig, H. I., Chen-Plotkin, A., Wolk, D. A., McCluskey, L. F., et al. (2017) · Alzheimer's Research & Therapy · doi:10.1186/s13195-017-0316-0 · Cited by 154
Tau and p-tau as CSF biomarkers in dementia: a meta-analysis
van Harten, A. C., Kester, M. I., Visser, P. J., Blankenstein, M. A., Pijnenburg, Y. A. L., van der Flier, W. M., & Scheltens, P. (2011) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.2011.086 · Cited by 168
Emerging role of microRNAs in major depressive disorder: diagnosis and therapeutic implications
Dwivedi, Y. (2014) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2014.16.1/ydwivedi · Cited by 169
Guedes, J. R., Custódia, C. M., Silva, R. J., de Almeida, L. P., Pedroso de Lima, M. C., & Cardoso, A. L. (2014) · Human Molecular Genetics · doi:10.1093/hmg/ddu348 · Cited by 170
Circulating microRNAs as biomarkers in cancer diagnosis
Sohel, M. M. H. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.117473 · Cited by 168
Neuronal dark matter: the emerging role of microRNAs in neurodegeneration
Goodall, E. F., Heath, P. R., Bandmann, O., Kirby, J., & Shaw, P. J. (2013) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2013.00178 · Cited by 187
The roles of amyloid precursor protein (APP) in neurogenesis
Zhou, Z., Chan, C. H.-S., Ma, Q., Xu, X., Xiao, Z., & Tan, E. (2011) · Cell Adhesion & Migration · doi:10.4161/cam.5.4.16986 · Cited by 179
Sørensen, S. S., Nygaard, A., & Christensen, T. (2016) · Translational Neurodegeneration · doi:10.1186/s40035-016-0053-5 · Cited by 167
Lu, Y., Tan, L., & Wang, X. (2019) · Neuroscience Bulletin · doi:10.1007/s12264-019-00361-0 · Cited by 168
Deregulated mitochondrial microRNAs in Alzheimer's disease: Focus on synapse and mitochondria
Gowda, P., Reddy, P. H., & Kumar, S. (2021) · Ageing Research Reviews · doi:10.1016/j.arr.2021.101529 · Cited by 170
Schönrock, N., Humphreys, D. T., Preiß, T., & Götz, J. (2011) · Journal of Molecular Neuroscience · doi:10.1007/s12031-011-9587-2 · Cited by 163
The Pervasive Role of the miR-181 Family in Development, Neurodegeneration, and Cancer
Indrieri, A., Carrella, S., Carotenuto, P., Banfi, S., & Franco, B. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21062092 · Cited by 164
The circular RNA ci RS ‐7 promotes APP and BACE 1 degradation in an NF ‐κB‐dependent manner
Shi, Z., Chen, T., Yao, Q., Zheng, L., Zhang, Z., Wang, J., Hu, Z., Cui, H., Han, Y., Han, X., et al. (2017) · FEBS Journal · doi:10.1111/febs.14045 · Cited by 160
Cosín‐Tomás, M., Antonell, A., Lladó, A., Alcolea, D. A., Fortea, J., Ezquerra, M., Lleó, A., Martı́, M. J., Pallàs, M., Sánchez‐Valle, R., et al. (2016) · Molecular Neurobiology · doi:10.1007/s12035-016-0088-8 · Cited by 161
Reduced expression of hsa-miR-27a-3p in CSF of patients with Alzheimer disease
Sala Frigerio, C., Lau, P., Salta, E., Tournoy, J., Bossers, K., Vandenberghe, R., Wallin, A., Bjerke, M., Zetterberg, H., Blennow, K., et al. (2013) · Neurology · doi:10.1212/01.wnl.0000437306.37850.22 · Cited by 156
Shigehara, K., Yokomuro, S., Ishibashi, O., Mizuguchi, Y., Arima, Y., Kawahigashi, Y., Kanda, T., Akagi, I., Tajiri, T., Yoshida, H., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0023584 · Cited by 156
Jin, X.-F., Wu, N., Wang, L., & Li, J. (2013) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-013-9940-9 · Cited by 159
MicroRNAs, Long Noncoding RNAs, and Their Functions in Human Disease
Xue, M., Zhuo, Y., & Shan, B. (2017) · Methods in molecular biology · doi:10.1007/978-1-4939-7046-9_1 · Cited by 154
miRNA-132: a dynamic regulator of cognitive capacity
Hansen, K. F., Karelina, K., Sakamoto, K., Wayman, G. A., Impey, S., & Obrietan, K. (2013) · Brain Structure and Function · doi:10.1007/s00429-012-0431-4 · Cited by 131
miRNA Expression Profiles in Cerebrospinal Fluid and Blood of Patients with Acute Ischemic Stroke
Sørensen, S. S., Nygaard, A., Nielsen, M., Jensen, K., & Christensen, T. (2014) · Translational Stroke Research · doi:10.1007/s12975-014-0364-8 · Cited by 150
Biomarkers for Alzheimer’s Disease Early Diagnosis
Ausó, E., Gómez‐Vicente, V., & Esquiva, G. (2020) · Journal of Personalized Medicine · doi:10.3390/jpm10030114 · Cited by 159
MicroRNAs as biomarkers for CNS cancer and other disorders
Smaele, E. D., Ferretti, E., & Gulino, A. (2010) · Brain Research · doi:10.1016/j.brainres.2010.03.103 · Cited by 154
MicroRNA-29a Is a Candidate Biomarker for Alzheimer’s Disease in Cell-Free Cerebrospinal Fluid
Müller, M., Jäkel, L., Bruinsma, I. B., Claassen, J. A. H. R., Kuiperij, H. B., & Verbeek, M. M. (2015) · Molecular Neurobiology · doi:10.1007/s12035-015-9156-8 · Cited by 147
Plasma microRNA biomarkers for detection of mild cognitive impairment: Biomarker Validation Study
Sheinerman, K. S., Tsivinsky, V. G., Abdullah, L. I., Crawford, F., & Umansky, S. R. (2013) · Aging · doi:10.18632/aging.100624 · Cited by 147
Millan, M. J. (2017) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2017.03.004 · Cited by 151
Watson, C. N., Belli, A., & Pietro, V. D. (2019) · Frontiers in Genetics · doi:10.3389/fgene.2019.00364 · Cited by 154
Persengiev, S. P., Kondova, I. I., Otting, Ń., Koeppen, A. H., & Bontrop, R. E. (2010) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2010.03.014 · Cited by 145
Delgado‐Morales, R., Agís‐Balboa, R. C., Esteller, M., & Berdasco, M. (2017) · Clinical Epigenetics · doi:10.1186/s13148-017-0365-z · Cited by 147
The Epigenetics of Alzheimer’s Disease: Factors and Therapeutic Implications
Liu, X., Jiao, B., & Shen, L. H. (2018) · Frontiers in Genetics · doi:10.3389/fgene.2018.00579 · Cited by 153
Epigenetics of Aging and Alzheimer’s Disease: Implications for Pharmacogenomics and Drug Response
Cacabelos, R., & Torrellas, C. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms161226236 · Cited by 144
Control of mitochondrial activity by miRNAs
Li, P., Jiao, J., Gao, G., & Prabhakar, B. S. (2011) · Journal of Cellular Biochemistry · doi:10.1002/jcb.24004 · Cited by 145
RNA metabolism in neurodegenerative disease
Liu, E. Y., Cali, C. P., & Lee, E. B. (2017) · Disease Models & Mechanisms · doi:10.1242/dmm.028613 · Cited by 138
Epigenetic mechanisms in Alzheimer's disease: Implications for pathogenesis and therapy
Wang, J., Yu, J., Tan, M., Jiang, T., & Tan, L. (2013) · Ageing Research Reviews · doi:10.1016/j.arr.2013.05.003 · Cited by 140
Donati, S., Ciuffi, S., & Brandi, M. L. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20184353 · Cited by 139
miRNAs and long noncoding RNAs as biomarkers in human diseases
Roosbroeck, K. V., Pollet, J. B. K., & Călin, G. A. (2013) · Expert Review of Molecular Diagnostics · doi:10.1586/erm.12.134 · Cited by 136
MicroRNAs in Human Cerebrospinal Fluid as Biomarkers for Alzheimer’s Disease
Lusardi, T. A., Phillips, J. I., Wiedrick, J. T., Harrington, C. A., Lind, B., Lapidus, J., Quinn, J. F., & Saugstad, J. A. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-160835 · Cited by 135
Emergence of exosomal miRNAs as a diagnostic biomarker for Alzheimer's disease
Giau, V. V., & An, S. S. A. (2015) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2015.12.005 · Cited by 133
The promise of microRNA-based therapies in Alzheimer’s disease: challenges and perspectives
Walgrave, H., Zhou, L., Strooper, B. D., & Salta, E. (2021) · Molecular Neurodegeneration · doi:10.1186/s13024-021-00496-7 · Cited by 137
Annese, A., Manzari, C., Lionetti, C., Picardi, E., Horner, D. S., Chiara, M., Caratozzolo, M. F., Tullo, A., Fosso, B., Pesole, G., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-22701-2 · Cited by 133
Genetic markers for diagnosis and pathogenesis of Alzheimer's disease
Kim, D., Yeo, S. H., Park, J.-M., Choi, J. Y., Lee, T.-H., Park, S. Y., Ock, M. S., Eo, J., Kim, H., & Cha, H. (2014) · Gene · doi:10.1016/j.gene.2014.05.031 · Cited by 133
Alternative polyadenylation and miR‐34 family members regulate tau expression
Dickson, J. R., Kruse, C., Montagna, D. R., Finsen, B. R., & Wolfe, M. S. (2013) · Journal of Neurochemistry · doi:10.1111/jnc.12437 · Cited by 128
Issues and Prospects of microRNA-Based Biomarkers in Blood and Other Body Fluids
Chevillet, J. R., Lee, I., Briggs, H., He, Y., & Wang, K. (2014) · Molecules · doi:10.3390/molecules19056080 · Cited by 129
Epigenomics of Alzheimer's disease
Bennett, D. A., Yu, L., Yang, J., Srivastava, G. P., Aubin, C., & Jager, P. L. D. (2014) · Translational research · doi:10.1016/j.trsl.2014.05.006 · Cited by 126
miRNAs: Key Players in Neurodegenerative Disorders and Epilepsy
Karnati, H. K., Panigrahi, M. K., Gutti, R. K., Greig, N. H., & Tamargo, I. A. (2015) · Journal of Alzheimer s Disease · doi:10.3233/jad-150395 · Cited by 126
The miRNome of Alzheimer's disease: consistent downregulation of the miR-132/212 cluster
Pichler, S., Gu, W., Hartl, D., Gasparoni, G., Leidinger, P., Keller, A., Meese, E., Mayhaus, M., Hampel, H., & Riemenschneider, M. (2017) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2016.09.019 · Cited by 108
MicroRNAs and deregulated gene expression networks in neurodegeneration
Sonntag, K. (2010) · Brain Research · doi:10.1016/j.brainres.2010.03.106 · Cited by 130
Causes and Consequences of MicroRNA Dysregulation in Neurodegenerative Diseases
Tan, L., Yu, J.-T., & Tan, L. (2014) · Molecular Neurobiology · doi:10.1007/s12035-014-8803-9 · Cited by 128
An ALS-associated mutation in the FUS 3′-UTR disrupts a microRNA–FUS regulatory circuitry
Modigliani, S. D., Morlando, M., Errichelli, L., Sabatelli, M., & Bozzoni, I. (2014) · Nature Communications · doi:10.1038/ncomms5335 · Cited by 127
Epigenetic Modifications of Major Depressive Disorder
Saavedra, K., Molina-Márquez, A., Saavedra, N., Zambrano, T., & Salazar, L. A. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17081279 · Cited by 129
MicroRNA and chronic pain: From mechanisms to therapeutic potential
López‐González, M. J., Landry, M., & Favereaux, A. (2017) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2017.06.001 · Cited by 126
MicroRNA‐138 promotes tau phosphorylation by targeting retinoic acid receptor alpha
Wang, X., Tan, L., Lu, Y., Peng, J., Zhu, Y., Zhang, Y., & Sun, Z. (2015) · FEBS Letters · doi:10.1016/j.febslet.2015.02.001 · Cited by 122
SIRT1, miR-132 and miR-212 link human longevity to Alzheimer’s Disease
Hadar, A., Milanesi, E., Walczak, M., Puzianowska‐Kuźnicka, M., Kuźnicki, J., Squassina, A., Niola, P., Chillotti, C., Attems, J., Gozes, I., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-26547-6 · Cited by 123
Derkow, K., Rößling, R., Schipke, C. G., Krüger, C., Bauer, J., Fähling, M., Stroux, A., Schott, E., Ruprecht, K., Peters, O., et al. (2018) · PLoS ONE · doi:10.1371/journal.pone.0200602 · Cited by 125
Hébert, S. S., Wang, W.-X., Zhu, Q., & Nelson, P. T. (2013) · Journal of Alzheimer's Disease · doi:10.3233/jad-122350 · Cited by 125
Maffioletti, E., Tardito, D., Gennarelli, M., & Bocchio‐Chiavetto, L. (2014) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2014.00075 · Cited by 126
Nagaraj, S., Zoltowska, K. M., Laskowska-Kaszub, K., & Wojda, U. (2018) · Ageing Research Reviews · doi:10.1016/j.arr.2018.10.008 · Cited by 123
microRNAs as neuroregulators, biomarkers and therapeutic agents in neurodegenerative diseases
Basak, I., Patil, K. S., Alves, G., Larsen, J. P., & Møller, S. G. (2016) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-015-2093-x · Cited by 107
Epigenetically regulated microRNAs in Alzheimer's disease
van den Hove, D., Kompotis, K., Lardenoije, R., Kenis, G., Mill, J. S., Steinbusch, H. W. M., Lesch, K., Fitzsimons, C. P., Strooper, B. D., & Rutten, B. P. F. (2013) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2013.10.082 · Cited by 121
Siedlecki‐Wullich, D., Català-Solsona, J., Fábregas, C., Hernández, I., Clarimón, J., Lleó, A., Boada, M., Saura, C. A., Rodrı́guez-Álvarez, J., & Miñano-Molina, A. J. (2019) · Alzheimer s Research & Therapy · doi:10.1186/s13195-019-0501-4 · Cited by 117
Synaptic Dysfunction in Alzheimer’s Disease: Aβ, Tau, and Epigenetic Alterations
Li, K., Wei, Q., Liu, F., Hu, F., Xie, A., Zhu, L., & Liu, D. (2017) · Molecular Neurobiology · doi:10.1007/s12035-017-0533-3 · Cited by 121
Deregulation of neuronal miRNAs induced by amyloid-β or TAU pathology
Sierksma, A., Lu, A., Salta, E., Vanden Eynden, E., Callaerts-Vegh, Z., D’Hooge, R., Blum, D., Buée, L., Fiers, M., & De Strooper, B. (2018) · Molecular Neurodegeneration · doi:10.1186/s13024-018-0285-1 · Cited by 120
Epigenetics: A novel therapeutic approach for the treatment of Alzheimer's disease
Adwan, L. I., & Zawia, N. H. (2013) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2013.03.010 · Cited by 118
Upcoming Candidate Cerebrospinal Fluid Biomarkers of Alzheimer’s Disease
Fagan, A. M., & Perrin, R. J. (2012) · Biomarkers in Medicine · doi:10.2217/bmm.12.42 · Cited by 118
The Brain-Enriched MicroRNA miR-9-3p Regulates Synaptic Plasticity and Memory
Sim, S.-E., Lim, C.-S., Kim, J.-I., Seo, D., Chun, H., Yu, N.-K., Lee, J., Kang, S. J., Ko, H.-G., Choi, J.-H., et al. (2016) · The Journal of Neuroscience · doi:10.1523/jneurosci.0630-16.2016 · Cited by 116
Quan, Z., Zheng, D., & Qing, H. (2017) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2017.00175 · Cited by 115
The Role of microRNAs in Alzheimer’s Disease and Their Therapeutic Potentials
Shaik, M. M., Tamargo, I. A., Abubakar, M. B., Kamal, M. A., Greig, N. H., & Gan, S. H. (2018) · Genes · doi:10.3390/genes9040174 · Cited by 117
Cheng, L., Quek, C. Y. J., Sun, X., Bellingham, S. A., & Hill, A. F. (2013) · Frontiers in Genetics · doi:10.3389/fgene.2013.00150 · Cited by 113
MiRNAs as Biomarkers of Myocardial Infarction: A Meta-Analysis
Cheng, C., Wang, Q., You, W.-J., Chen, M., & Xia, J. (2014) · PLoS ONE · doi:10.1371/journal.pone.0088566 · Cited by 115
Lee, K., Kim, J. H., Kwon, O. B., An, K., Ryu, J., Cho, K., Suh, Y. H., & Kim, H.-S. (2012) · Journal of Neuroscience · doi:10.1523/jneurosci.6471-11.2012 · Cited by 114
Yang, G., Song, Y.-M., Zhou, X.-Y., Deng, Y.-D., Liu, T., Weng, G., Yu, D., & Pan, S.-Y. (2015) · Molecular Medicine Reports · doi:10.3892/mmr.2015.3728 · Cited by 109
MicroRNA in Alzheimer’s disease: an exploratory study in brain, cerebrospinal fluid and plasma
Bekris, L. M., Lutz, F., Montine, T. J., Yu, C. E., Tsuang, D., Peskind, E. R., & Leverenz, J. B. (2013) · Biomarkers · doi:10.3109/1354750x.2013.814073 · Cited by 97
RNA and Oxidative Stress in Alzheimer’s Disease: Focus on microRNAs
Nunomura, A., & Perry, G. L. (2020) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2020/2638130 · Cited by 111
Liang, C., Zhu, H., Xu, Y., Huang, L. J., Ma, C., Deng, W., Liu, Y. M., & Qin, C. (2011) · Brain Research · doi:10.1016/j.brainres.2011.10.051 · Cited by 111
The beclin 1 interactome: Modification and roles in the pathology of autophagy-related disorders
Kaur, S., & Changotra, H. (2020) · Biochimie · doi:10.1016/j.biochi.2020.04.025 · Cited by 116
A combined miRNA-piRNA signature to detect Alzheimer’s disease
Jain, G., Stuendl, A., Rao, P., Berulava, T., Pena Centeno, T., Kaurani, L., Burkhardt, S., Delalle, I., Kornhuber, J., Hüll, M., et al. (2019) · Translational Psychiatry · doi:10.1038/s41398-019-0579-2 · Cited by 121
Alzheimer’s Disease: Biomarkers in the Genome, Blood, and Cerebrospinal Fluid
Huynh, R. A., & Mohan, C. (2017) · Frontiers in Neurology · doi:10.3389/fneur.2017.00102 · Cited by 112
Epigenetic memory: The Lamarckian brain
Fischer, A. (2014) · The EMBO Journal · doi:10.1002/embj.201387637 · Cited by 107
The roles of circular RNAs in human development and diseases
Lee, E. C. S., Elhassan, S. A. M., Lim, G. P. L., Kok, W. H., Tan, S. W., Leong, E. N., Tan, S. H., Chan, E. W. L., Bhattamisra, S. K., Rajendran, R., et al. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.12.052 · Cited by 106
Barros-Viegas, A. T., Carmona, V., Ferreiro, E. B., Guedes, J. R., Cardoso, A. M., Cunha, P. S., de Almeida, L. P., Oliveira, C. R., Peça, J., Peça, J., et al. (2020) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2020.01.010 · Cited by 112
microRNA‐132: a key noncoding RNA operating in the cellular phase of Alzheimer's disease
Salta, E., & De Strooper, B. (2017) · The FASEB Journal · doi:10.1096/fj.201601308 · Cited by 99
MicroRNAs as Biomarkers in Amyotrophic Lateral Sclerosis
Ricci, C., Marzocchi, C., & Battistini, S. (2018) · Cells · doi:10.3390/cells7110219 · Cited by 107
Ren, S., Lin, P., Wang, J., Yu, H., Lv, T., Sun, L., & Du, G. (2020) · Molecular Therapy — Methods & Clinical Development · doi:10.1016/j.omtm.2020.05.027 · Cited by 107
Targeted deletion of miR-132/-212 impairs memory and alters the hippocampal transcriptome
Hansen, K. F., Sakamoto, K., Aten, S., Price, K. H., Loeser, J., Hesse, A. M., Page, C. E., Pelz, C., Arthur, J. S. C., Impey, S., et al. (2016) · Learning & Memory · doi:10.1101/lm.039578.115 · Cited by 100
Brain Derived Exosomes Are a Double-Edged Sword in Alzheimer’s Disease
Song, Z., Xu, Y., Deng, W., Zhang, L., Zhu, H., Yü, P., Qu, Y., Zhao, W., Han, Y., & Qin, C. (2020) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2020.00079 · Cited by 103
MicroRNA-132, -134, and -138: a microRNA troika rules in neuronal dendrites
Bicker, S., Lackinger, M., Weiß, K., & Schratt, G. (2014) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-014-1671-7 · Cited by 102
Converging miRNA functions in diverse brain disorders: A case for miR-124 and miR-126
Sonntag, K., Woo, T.-U. W., & Krichevsky, A. M. (2011) · Experimental Neurology · doi:10.1016/j.expneurol.2011.11.035 · Cited by 107
Drusco, A., Bottoni, A., Laganà, A., Acunzo, M., Fassan, M., Cascione, L., Antenucci, A., Kumchala, P., Vicentini, C., Gardiman, M. P., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.4096 · Cited by 103
A panel of four decreased serum microRNAs as a novel biomarker for early Parkinson’s disease
Dong, H., Wang, C., Lu, S., Yu, C., Huang, L., Feng, W., Xu, H., Chen, X., Zen, K., Yan, Q., et al. (2015) · Biomarkers · doi:10.3109/1354750x.2015.1118544 · Cited by 103
miRNAs as Biomarkers and Therapeutic Targets in Non-Small Cell Lung Cancer: Current Perspectives
Florczuk, M., Szpechciński, A., & Chorostowska‐Wynimko, J. (2017) · Targeted Oncology · doi:10.1007/s11523-017-0478-5 · Cited by 104
MicroRNAs as biomarkers of disease onset
Cieśla, M., Skrzypek, K., Kozakowska, M., Łoboda, A., Józkowicz, A., & Dulak, J. (2011) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-011-5001-8 · Cited by 106
miR‐186 is decreased in aged brain and suppresses BACE 1 expression
Kim, J., Yoon, H., Chung, D., Brown, J. L., Belmonte, K. C., & Kim, J. (2016) · Journal of Neurochemistry · doi:10.1111/jnc.13507 · Cited by 102
Higaki, S., Muramatsu, M., Matsuda, A., Matsumoto, K., Satoh, J., Michikawa, M., & Niida, S. (2018) · PLoS ONE · doi:10.1371/journal.pone.0196929 · Cited by 103
microRNA-Based Biomarkers in Alzheimer’s Disease (AD)
Zhao, Y., Jaber, V. R., Alexandrov, P. N., Vergallo, A., Lista, S., Hampel, H. J., & Lukiw, W. J. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.585432 · Cited by 99
Metadata
- Authors
- Cogswell, J. P., Ward, J., Taylor, I. A., Waters, M., Shi, Y., Cannon, B., Kelnar, K., Kemppainen, J., Brown, D., Chen, C., Prinjha, R. K., Richardson, J. C., Saunders, A. M., Roses, A. D., & Richards, C. A.
- Affiliations
- GlaxoSmithKline (United States) (US)
- Asuragen (United States) (US)
- Molecular Cell Biology-RandD, Applied Biosystems Foster City, CA, USA
- GlaxoSmithKline (United Kingdom) (GB)
- Venue
- Journal of Alzheimer s Disease
- Publisher
- SAGE Publications
- Published
- 2008-05-09
- Volume
- 14
- Issue
- 1
- Pages
- 27-41
- ISSN
- 1387-2877 (ISSN-L)
- 1875-8908
- OpenAlex
- W32204808
- Cited by
- 943
- References
- 65
- Citations by year
- 2026: 15 · 2025: 32 · 2024: 28 · 2023: 35 · 2022: 50 · 2021: 78 · 2020: 62 · 2019: 60 · 2018: 69 · 2017: 65 · 2016: 64 · 2015: 83 · 2014: 71 · 2013: 74 · 2012: 50
- FWCI
- 12.06
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Alzheimer s Disease (publishedVersion)
- PubMed (publishedVersion)
- Funders
- GlaxoSmithKline
- National Institute on Aging (NIA AG05128)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › MicroRNA in disease regulation
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Keywords
- Alzheimer's disease, microRNA
- MeSH terms
- Aged, Aged, 80 and over, Alzheimer Disease, Amyloid, Brain, Cerebellum, Female, Frontal Lobe, Gene Expression Regulation, Genetic Markers, Hippocampus, Humans, Immunity, Innate, Insulin Resistance, Male, Middle Aged, Neurons, RNA, Messenger, Transfection, Biomarkers, Reverse Transcriptase Polymerase Chain Reaction, MicroRNAs, Cell Line, Tumor
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
